Definition of primary and secondary glioblastoma - Letter

Clinical Cancer Research

Volumn 20, Issue 7, 2014, Pages 2011-2012

  Werner, Peter ^a   Fritzsch, Dominik ^a   Holland, Heidrun ^b   Bauer, Manfred ^a   Krupp, Wolfgang ^a   Hoffmann, Karl Titus ^a   Saur, Dorothee ^a   Bergh, Florian Then ^a   Sabri, Osama ^a   Barthel, Henryk ^a  

^a UNIVERSITY HOSPITAL LEIPZIG   (Germany)

^b UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID TRANSPORT; ASTROCYTOMA; DIFFERENTIAL DIAGNOSIS; GLIOBLASTOMA; HUMAN; LETTER; MALIGNANT TRANSFORMATION; MOLECULAR GENETICS; MOLECULAR IMAGING; NEUROIMAGING; POSITRON EMISSION TOMOGRAPHY; PRIMARY GLIOBLASTOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SECONDARY GLIOBLASTOMA; BRAIN TUMOR; GENETICS; OLIGODENDROGLIOMA; SECONDARY;

ISOCITRATE DEHYDROGENASE;

BRAIN NEOPLASMS; GLIOBLASTOMA; HUMANS; ISOCITRATE DEHYDROGENASE; OLIGODENDROGLIOMA;

EID: 84898717339     PISSN: 10780432     EISSN: 15573265     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-13-3190     Document Type: Letter

References (5)

1. Ohgaki H, Kleihues P. The definition of primary and secondary glioblastoma. Clin Cancer Res 2013;19:764-72.
2. Ullrich RT, Kracht L, Brunn A, Herholz K, Frommolt P, Miletic H, et al. Methyl-L-11C-methionine PET as a diagnostic marker for malignant progression in patients with glioma. J Nucl Med 2009;50:1962-8.
3. La Fougère C, Suchorska B, Bartenstein P, Kreth F-W, Tonn J-C. Molecular imaging of gliomas with PET: opportunities and limitations. Neuro Oncol 2011;13:806-19.
4. Catana C, Drzezga A, Heiss W-D, Rosen BR. PET/MRI for neurologic applications. J Nucl Med 2012;53:1916-25.
5. Heiss W-D, Raab P, Lanfermann H. Multimodality assessment of brain tumors and tumor recurrence. J Nucl Med 2011;52:1585-600.